Effectiveness of Solifenacin versus Mirabegron in the Treatment of Overactive Bladder: A Prospective Cohort Study
Introduction: Overactive Bladder (OAB) syndrome is a symptom-complex defined as urinary urgency, usually accompanied by increased daytime frequency and nocturia, with or without urgency incontinence, in the absence of urinary tract infection or other obvious pathology. Aim: To compare the efficacy...
Saved in:
Main Authors: | Shyamali Dutta, Korlapally Divya Bhavani, Avik Das, Debadrita Das, Palash Mazumder |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2025-07-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2025&month=July&volume=19&issue=7&page=QC14-QC17&id=21268 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study
by: Jae Hun Shim, et al.
Published: (2021-04-01) -
Treatment of overactive bladder symptoms in women with Diunorm®: preliminary results report
by: S. V. Shkodkin, et al.
Published: (2021-07-01) -
The Impact of Real-world Use of Overactive Bladder Medications on Dementia Risk in Younger Adults
by: Bruce Li, et al.
Published: (2025-08-01) -
The peptide regulator Vezusten in the management of overactive bladder syndrome: an efficacy evaluation
by: G. V. Kovalev, et al.
Published: (2024-09-01) -
Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females
by: Claudia Covarrubias, et al.
Published: (2025-06-01)